Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155219852146
Abstract: Introduction Ibrutinib, an oral inhibitor of Bruton’s tyrosine kinase, has altered the treatment perspective of chronic lymphocytic leukemia and showed modest activity against several types of non-Hodgkin’s lymphomas. According to phase studies and real-world data,… read more here.
Keywords: late onset; onset left; dysfunction cardiomyopathy; ventricular dysfunction ... See more keywords